logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals

Small Cap•1,470 Employees•IPO 2007
Current Price
₹413.40
-6.9 (-1.64%)Updated
NSE :SMSPHARMA
BSE :532815
Sector :Pharmaceuticals
Today's Range
411.05
₹413.40
indicator
433.9
52 Week Range
52W Low₹186.62
52W High₹423.90
₹413.40
indicator
Downside121.52%
Upside2.54%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹3,443.59 Cr
Market Cap
Total market value of company
P/E Ratio
37.82
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
3.15
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹9.69
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
6.67%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
12.50%
ROCE
Return on Capital Employed. >15% is good
Net Margin
9.81%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
16.97%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
13.70%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
19.20%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
24.30%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.49
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹72.15
Book Value
Net asset value per share
Dividend Yield
0.22%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
68.10%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • •Promoter holding consistently increased to 68.07% by September 2025.
  • •Achieved 19.20% quarterly sales growth and 24.30% profit increase.

Weaknesses

5 points
  • •ROCE at 12.50% and ROE at 11.80% are lower than peers.
  • •P/E ratio of 36.90 is higher than the sector average.

Opportunities

4 points
  • •Pharmaceuticals industry benefits from increasing global demand for medicines.
  • •Smaller market cap (2699 Cr) allows significant growth potential.

Threats

4 points
  • •Faces stiff competition from larger, established players like Divi's Lab.
  • •Highly regulated industry; policy changes could impact operational costs.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Ramesh Babu Potluri
27 Mar 202531 Mar 20251.82 Cr
25.00 L
₹95.25BUY
POTLURI INFRA PROJECTS LLP
27 Mar 202531 Mar 202588.46 L
15.00 L
₹95.25BUY
Hima Bindu Potluri
25 Mar 202531 Mar 20251.50 Cr
30.00 L
₹227.65BUY
POTLURI INFRA PROJECTS LLP
25 Mar 202531 Mar 202573.46 L
73.46 L
₹227.65BUY
Potluri Laboratories Private Limited
25 Mar 202531 Mar 202511.20 L
11.20 L
₹227.65BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹473.55+₹60.15+14.55%
R3₹450.70+₹37.30+9.02%
R2₹442.30+₹28.90+6.99%
R1₹427.85+₹14.45+3.50%
PIVOT₹419.456.051.46%
CURRENT₹413.40--
S1₹359.30-₹54.10-13.09%
S2₹382.15-₹31.25-7.56%
S3₹396.60-₹16.80-4.06%
S4₹405.00-₹8.40-2.03%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
7.74L
(11 Mar 2026)
+25.4% vs avg
Delivery %
29.5%
(11 Mar 2026)
-3.4% vs avg
Avg Volume (20D)
6.17L
(11 Feb - 11 Mar)
20-day average
Avg Delivery %
32.9%
(11 Feb - 11 Mar)
Trend ↓
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Solara Active Pharma Sciences Ltd
178.00 %
Highest Dividend Yield
RPG Life Sciences Ltd
1.22 %

Peer Comparison

Company Name
AARTIDRUGS
Aarti Drugs Ltd
AMRUTANJAN
Amrutanjan Health Care Ltd
BETA
Beta Drugs Ltd
BLISSGVS
Bliss GVS Pharma Ltd
GUFICBIO
Gufic BioSciences Ltd
HIKAL
Hikal Ltd
INDOCO
Indoco Remedies Ltd
IOLCP
IOL Chemicals & Pharmaceuticals Ltd
MOREPENLAB
Morepen Laboratories Ltd
ORCHPHARMA
Orchid Pharma Ltd
RPGLIFE
RPG Life Sciences Ltd
SENORES
Senores Pharmaceuticals Ltd
SOLARA
Solara Active Pharma Sciences Ltd
SPARC
Sun Pharma Advanced Research Company Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd
SUPRIYA
Supriya Lifescience Ltd
TTKHLTCARE
TTK Healthcare Ltd
UNICHEMLAB
Unichem Laboratories Ltd
ZOTA
Zota Health Care Ltd

About

SMSPHARMA

SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited is an Indian pharmaceutical company specializing in the manufacturing and sale of active pharmaceutical ingredients (APIs) and their intermediates. Their operations span both domestic and international markets, demonstrating a significant global reach. The company boasts a diverse product portfolio catering to various therapeutic areas, showcasing a wide range of expertise in API development and production.

Their product offerings encompass a broad spectrum of therapeutic applications. This includes crucial medications for treating conditions such as retroviral infections (like HIV/AIDS), inflammation, viral infections, diabetes, fungal infections, epilepsy, migraines, blood clots, psychotic disorders, angina (chest pain), and ulcers. This breadth of therapeutic areas served indicates a commitment to addressing diverse healthcare needs across a substantial patient population.

Beyond their core API manufacturing and sales, SMS Pharmaceuticals also undertakes contract research, specifically focusing on peptide research. This demonstrates an investment in research and development, enabling the company to potentially expand its product offerings and strengthen its technological capabilities within the pharmaceutical sector. The contract research activities might also generate additional revenue streams and allow for collaborations with other research institutions or pharmaceutical companies.

The company's extensive export network, reaching approximately 75 countries globally, underscores its substantial international presence and market penetration. This highlights a successful strategy in establishing and maintaining relationships with international partners and distributors, thereby solidifying their position within the global pharmaceutical landscape. This broad export reach contributes significantly to the company's overall revenue and reinforces its reputation as a prominent player in the international API market.

Established in 1987 and headquartered in Hyderabad, India, SMS Pharmaceuticals has a long history in the pharmaceutical industry. This long-standing presence suggests a proven track record of consistent performance, regulatory compliance, and the establishment of robust operational processes within the competitive pharmaceutical manufacturing sector. Their continued success reflects adaptability to market changes and a strong commitment to meeting the evolving needs of the global healthcare community.

COMPANY FACTS - SMSPHARMA

Registered Address

Plot No.72, H. No.8-2-334/3 & 4 Road No.5, Opp. SBI Executive Enclave, Banjara Hills

Hyderabad

TELANGANA

IN

Tel: 914066288888

Website:https://smspharma.com/

Investor Relations:http://smspharma.com/annual-report/
Company Details

Group: Pharmaceuticals, Biotechnology & Life Sciences

Sector: Health Care

Industry: Pharmaceuticals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 1,470

IPO Date: 25/02/2007

MANAGEMENT - SMSPHARMA

Shri. Ramesh Potluri

Executive Chairman of the Board, Managing Director

Sri. Lakshmi Tammineedi

Chief Financial Officer

Mr. Thirumalesh Tumma

Chief Compliance Officer, Company Secretary

Mr. Vamsi Potluri

Additional Director

Mr. Trilok Potluri

Non-Executive Non-Independent Director

Dr. Sunkara Prasad

Non-Executive Non Independent Director

Mrs. Shanti Bolleni

Non-Executive Independent Director

Dr. Suresh Gangavarapu

Non-Executive Independent Director

Mr. Shravan Kudaravalli

Non-Executive Independent Director

Mr. Sarvepalli Srinivas

Additional Non-Executive Independent Director

Investor Questions Answered

SMS Pharmaceuticals Ltd (SMSPHARMA) Stock FAQs

Get answers to the most common questions about SMS Pharmaceuticals Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of SMS Pharmaceuticals Ltd (SMSPHARMA) is ₹413.4. Today, the stock has declined by ₹6.90 (1.64%), trading in a range of ₹411.05 to ₹433.9. The stock opened at ₹422 with a trading volume of 7,73,687 shares.
SMS Pharmaceuticals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,443.59 crores, P/E ratio of 37.82, ROE of 6.67%, and ROCE of 12.50%. The dividend yield stands at 0.22%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of SMS Pharmaceuticals Ltd (SMSPHARMA) is ₹423.9, while the 52-week low is ₹186.62. Currently trading at ₹413.4, the stock is 95.6% away from its 52-week low and 2.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy SMS Pharmaceuticals Ltd stock at ₹413.4 depends on multiple factors. The stock is currently trading with a P/E ratio of 37.82 and P/B ratio of N/A. Today's performance shows a loss of 1.64%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
SMS Pharmaceuticals Ltd offers a dividend yield of 0.22%, which means for every ₹100 invested at the current price of ₹413.4, you can expect to receive approximately ₹0.22 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
SMS Pharmaceuticals Ltd's key financial metrics include: P/E Ratio: 37.82, P/B Ratio: N/A, ROE: 6.67%, ROCE: 12.50%, Dividend Yield: 0.22%, EPS: ₹9.69, Book Value: ₹72.15, Debt-to-Equity: 0.49, and Current Ratio: N/A. The company's market cap stands at ₹3,443.59 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
SMS Pharmaceuticals Ltd stock opened at ₹422 and is currently trading at ₹413.4, showing a decline of ₹6.90 (1.64%). The intraday high is ₹433.9 and low is ₹411.05. The trading volume stands at 7,73,687 shares, indicating moderate market participation today.
SMS Pharmaceuticals Ltd has a Price-to-Earnings (P/E) ratio of 37.82, which means investors are willing to pay ₹37.82 for every ₹1 of earnings. With an EPS of ₹9.69, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
SMS Pharmaceuticals Ltd has a market capitalization of ₹3,443.59 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹413.4) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
SMS Pharmaceuticals Ltd has a book value of ₹72.15 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹413.4, which is 473.0% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
SMS Pharmaceuticals Ltd has a Return on Equity (ROE) of 6.67% and Return on Capital Employed (ROCE) of 12.50%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
SMS Pharmaceuticals Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
SMS Pharmaceuticals Ltd has a debt-to-equity ratio of 0.49, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
SMS Pharmaceuticals Ltd has an Earnings Per Share (EPS) of ₹9.69, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹413.4 and P/E ratio of 37.82, investors are paying 37.82 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
SMS Pharmaceuticals Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
SMS Pharmaceuticals Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze SMS Pharmaceuticals Ltd stock, consider: 1) Fundamental Analysis - Review P/E (37.82), ROE (6.67%), debt-to-equity (0.49), and growth rates. 2) Technical Analysis - Check 52-week range (₹186.62 - ₹423.90), moving averages, and chart patterns. 3) Valuation - Compare current price (₹413.40) with book value (₹72.15) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of SMS Pharmaceuticals Ltd share is ₹1.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹413.4 is 41240x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in SMS Pharmaceuticals Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹186.62 - ₹423.90). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.49 indicates leverage. 4) Liquidity Risk - Based on trading volume of 7,73,687 shares. 5) Valuation Risk - P/E of 37.82 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
SMS Pharmaceuticals Ltd operates in the industry with key metrics: P/E ratio of 37.82, ROE of 6.67%, market cap of ₹3,443.59 crores, and dividend yield of 0.22%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.49), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for SMS Pharmaceuticals Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹413.4, with a 52-week range of ₹186.62 to ₹423.90. Based on fundamentals like P/E (37.82), ROE (6.67%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling SMS Pharmaceuticals Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹413.40. 2) Fundamental Deterioration - Declining ROE (currently 6.67%), increasing debt (D/E: 0.49), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for SMS Pharmaceuticals Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.22%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.